Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Healius Limited (HLS) vs. Competitors

69 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AU:HLSHealius LimitedAUD 0.58AUD 392.14M-1.00-35.75%HoldUnlock the AU:HLS analyst price target with TipRanks PremiumAU:HLSUnlock the AU:HLS top-analyst price target with TipRanks Premium
AU:LDXLumos Diagnostics Holdings Ltd.AUD 0.07AUD 70.16M-7.29-65.00%Moderate BuyUnlock the AU:LDX analyst price target with TipRanks PremiumAU:HLS vs AU:LDXUnlock the AU:LDX top-analyst price target with TipRanks Premium
AU:SHLSonic Healthcare LimitedAUD 19.89AUD 9.85B16.17-6.44%HoldUnlock the AU:SHL analyst price target with TipRanks PremiumAU:HLS vs AU:SHLUnlock the AU:SHL top-analyst price target with TipRanks Premium
AU:IDXIntegral Diagnostics Ltd.AUD 1.67AUD 634.92M28.32-34.96%Moderate BuyUnlock the AU:IDX analyst price target with TipRanks PremiumAU:HLS vs AU:IDXUnlock the AU:IDX top-analyst price target with TipRanks Premium
AU:ACLAustralian Clinical Labs LtdAUD 3.35AUD 621.11M27.1024.54%HoldUnlock the AU:ACL analyst price target with TipRanks PremiumAU:HLS vs AU:ACLUnlock the AU:ACL top-analyst price target with TipRanks Premium
AU:MVFMonash IVF Group LtdAUD 0.75AUD 294.17M39.2723.97%Moderate BuyUnlock the AU:MVF analyst price target with TipRanks PremiumAU:HLS vs AU:MVFUnlock the AU:MVF top-analyst price target with TipRanks Premium

Performance Comparison

-75%-50%-25%0%25%50%75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AU:HLSHealius Limited0.57-0.33-36.46%
AU:LDXLumos Diagnostics Holdings Ltd.0.07-0.12-63.16%
AU:SHLSonic Healthcare Limited19.89-0.06-0.29%
AU:IDXIntegral Diagnostics Ltd.1.67-0.74-30.68%
AU:ACLAustralian Clinical Labs Ltd3.350.8031.58%
AU:MVFMonash IVF Group Ltd0.750.1729.53%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts